Comprehensive Analysis of Lung Cancer Metastasis: Sites, Rates, Survival, and Risk Factors—A Systematic Review and Meta‐Analysis
The Clinical Respiratory Journal · 2025-07 · 19 (7)
DOI: 10.1111/crj.70107 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Clinical Respiratory Journal, online erschienen am 11.07.2025. Verfasst von Shilin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, People's Republic of China. Hauptthemen laut MEDLINE: Lung Neoplasms, Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chongqing Medical Scientific Research Project, National Natural Science Foundation of China, Chongqing Talents Program - Contracted Management System Project.
Abstract (Originalsprache)
Objectives
Lung cancer metastasis constitutes a critical aspect of disease progression and patient outcomes. It is imperative to illuminate the complex landscape of lung cancer metastasis, offering a thorough evaluation of sites, rates, risk factors, and survival implications.
Methods
Studies on the prevalence of lung cancer metastasis, the risk factors, the overall survival (OS) after metastasis, or the risk factors for OS were included. Two independent reviewers used a standardized data extraction and quality assessment form. Hazard ratios and confidence intervals were calculated using random‐effects or fixed‐effects models.
Results
This systematic meta‐analysis included 115 clinical trials. Prevalent metastatic sites in non‐small cell lung carcinoma (NSCLC) encompassed brain (29%), bone (25%), adrenal gland (15%), liver (13%), and skin (3%). However, small cell lung carcinoma (SCLC) primarily metastasized to liver (33%), brain (30%), bone (27%), adrenal gland (10%), and pericardium (3%). The risk factors for brain metastases in NSCLC included lung adenocarcinoma, EGFR mutations, and prophylactic cranial irradiation (PCI); in SCLC brain metastasis, age and PCI were influential. The median OS after brain metastasis in NSCLC and SCLC was 21.3 and 10.5 months, respectively, while liver or bone metastases were notably linked to poorer survival. The factors influencing OS in NSCLC brain metastasis included age, EGFR mutations, and stereotactic radiosurgery. For SCLC brain metastasis, OS was notably impacted by gender, smoking status, the number of brain metastases, and radiotherapy.
Conclusion
This study provided insights into lung cancer metastasis. The results revealed the metastatic rates, risk factors, and OS to assist clinical decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, People's Republic of China.
- Department of Rehabilitation, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
ORCID-Profile: Fu Jin, Huanli Luo
Förderung
- Chongqing Medical Scientific Research Project
- National Natural Science Foundation of China
- Chongqing Talents Program - Contracted Management System Project
Zitieren
APA
Wang, S., Tang, W., Jin, F., Luo, H., Yang, H., & Wang, Y. (2025). Comprehensive Analysis of Lung Cancer Metastasis: Sites, Rates, Survival, and Risk Factors—A Systematic Review and Meta‐Analysis. The Clinical Respiratory Journal, 19(7). https://doi.org/10.1111/crj.70107
Vancouver
Wang S, Tang W, Jin F, Luo H, Yang H, Wang Y. Comprehensive Analysis of Lung Cancer Metastasis: Sites, Rates, Survival, and Risk Factors—A Systematic Review and Meta‐Analysis. The Clinical Respiratory Journal. 2025;19(7). doi:10.1111/crj.70107
BibTeX
@article{Wang2025,
author = {Wang, Shilin and Tang, Wen and Jin, Fu and Luo, Huanli and Yang, Han and Wang, Ying},
title = {Comprehensive Analysis of Lung Cancer Metastasis: Sites, Rates, Survival, and Risk Factors—A Systematic Review and Meta‐Analysis},
journal = {The Clinical Respiratory Journal},
year = {2025},
volume = {19},
number = {7},
doi = {10.1111/crj.70107}
}
EUVIMED